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Background: Elevated natriuretic peptides provide strong prognostic information in patients with heart failure (HF). The role of novel biomarkers 
in HF needs to be established. Our objective was to evaluate the prognostic power of novel biomarkers, incremental to the N- terminal part of the 
natriuretic peptide (NT-proBNP) in chronic HF.
methods: Levels of circulating NT-proBNP, Growth Differentiation Factor 15 (GDF-15), high sensitive C-Reactive Protein (hs-CRP), Galectin-3 (Gal-3) 
and high sensitive Troponin T (hs-TnT) were measured and related to all-cause long-term mortality. Of 209 patients (age 71 ± 10 years, 73% males, 
97% NYHA class III), 151 (72 %) died during a median follow-up of 8.7 ± 1 year.
results: The calculated area under the curve for NT-proBNP was 0.63, GDF-15 0.78, hs-CRP 0.66, Gal-3 0.68, and hs-TnT 0.68 (all; p <0.01). Each 
marker was predictive for mortality in univariate analysis. In multivariate analysis, elevated levels of GDF-15 (HR 1.41, CI 1.1-178, p=0.005), hs-CRP 
(HR 1.38, CI 1.15-1.67, p=0.001) and hs-TnT (HR 1.27, CI 1.06-1.53, p=0.008) were independently related to mortality. All novel markers had an 
incremental value to NT-proBNP, using the integrated discrimination improvement.
conclusion: In chronic HF, GDF-15, hs-CRP and hs-TnT are independent prognostic markers, incremental to NT-proBNP, in predicting long-term 
mortality. In this study, GDF-15 is the most predictive marker, even stronger than NT-proBNP. 
Multivariate Cox-proportional hazard analysis (n=209)
Variable GDF-15 (per SD) Z p-value hs-CRP (per SD) Z p-value Galectin-3 (per SD) Z p-value hs-TnT (per SD) Z p-value
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Univariate 1.69 (1.43-1.98) 6.31 < 0.001 1.55 (1.31-1.83) 5.15 < 0.001 1.41 (1.20-1.64) 4.30 < 0.001 1.53 (1.32-1.78) 5.65 < 0.001
Model 1 1.56 (1.31-1.86) 4.94 < 0.001 1.47 (1.26-1.73) 4.70 < 0.001 1.30 (1.10-1.53) 3.11 0.002 1.45 (1.24-1.71) 4.54 < 0.001
Model 2 1.45 (1.18-1.79) 3.45 0.001 1.42 (1.19-1.70) 3.93 < 0.001 1.27 (1.04-1.57) 2.35 0.019 1.36 (1.14-1.62) 3.39 0.001
Model 3 1.41 (1.11-1.78) 2.81 0.005 1.38 (1.15-1.67) 3.41 0.001 1.06 (0.84-1.32) 0.47 0.638 1.27 (1.06-1.53) 2.63 0.008
GDF-15, Growth differentiation factor 15; hs-CRP, high-sensitive C-reactive protein; HR, Hazard ratio; 95% CI, 95% Confidence interval; HF, Heart failure;
eGFR, estimated glomerular filtration rate; NT-proBNP, N-terminal pro brain natriuretic peptide.
Model 1: adjusted for age and gender
Model 2: adjusted for model 1 + renal function (eGFR), HF etiology and NT-proBNP
Model 3: adjusted for model 2 + novel biomarkers (combination of GDF-15, hs-TnT, Gal-3 and/or hs-CRP)
